Santen Pharmaceutical

Santen Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company specializing in ophthalmic treatments. The company was founded in 1890 and is headquartered in Osaka, Japan. Santen focuses on developing, producing and marketing prescription ophthalmic products, over-the-counter eye drops, and medical devices.
History and milestones
Santen was originally founded in 1890 as Kobe Santa Corporation, a wholesaler of Western medicines. In 1917, the company changed its name to Santen Pharmaceutical Co., Ltd. and shifted its focus to ophthalmology.
Throughout the 20th century, Santen developed and marketed various ophthalmic treatments, including solutions for cataracts, dry eye syndrome, glaucoma, and others. In the 1960s and 1970s, the company expanded its global presence, establishing subsidiaries and joint ventures in Europe, North America, and Asia.
In the 1980s, Santen began developing and manufacturing intraocular lenses for cataract surgery. In 1989, the company opened a research and development center in Tsukuba, Japan, to further its innovative treatments and medical devices.
In recent years, Santen has continued to expand its portfolio and global presence through acquisitions and partnerships. In 2010, the company acquired the U.S.-based company, ISTA Pharmaceuticals, to further its presence in the U.S. In 2011, Santen acquired the Japanese company, Ophthalmics Inc., and in 2014, the company established a joint venture with GlaxoSmithKline to develop and commercialize innovative ophthalmic products.
Products and Sectors
Santen specializes in prescription ophthalmic products, over-the-counter eye drops, and medical devices for various eye conditions. The company has a wide portfolio of products targeting various eye diseases, including dry eye syndrome, glaucoma, cataracts, and retinal disorders.
Santen’s key products include Ikervis, a prescription eye drop for the treatment of severe dry eye in Europe and other countries, and Taflotan, a prescription eye drop for the treatment of glaucoma in Europe and Asia.
In addition to pharmaceutical treatments, Santen also produces medical devices, including intraocular lenses, surgical instruments, and diagnostic equipment for cataracts and other eye conditions.
Research and Development
Santen invests a significant portion of its revenue into research and development (R&D). The company has established research facilities in Japan, the U.S., Europe, and China to develop innovative treatments for eye diseases. With over 1,600 employees dedicated to R&D, Santen’s efforts have led to the development of numerous innovative treatments and medical devices.
Sustainability
Santen is committed to sustainability and corporate social responsibility. The company has established initiatives to reduce its environmental impact, promote diversity and inclusion, and contribute to the community through various programs and partnerships.
In 2019, Santen joined the United Nations Global Compact, the world’s largest corporate sustainability initiative, and pledged to align its operations with the Ten Principles of the UN Global Compact in the areas of human rights, labor, environment, and anti-corruption.
Conclusion
Santen Pharmaceutical Co., Ltd. is a leading ophthalmic-focused pharmaceutical company with a long history of developing innovative treatments and medical devices for eye diseases. Through its commitment to R&D and sustainability, Santen remains dedicated to improving the lives of those suffering from eye conditions globally.

VGhlcmUgYX JlIGEgZmV3 IHVuaXF1ZS Bhc3BlY3Rz IHRoYXQgc2 V0IHRoZSBT YW50ZW4gUG hhcm1hY2V1 dGljYWwgY2 9tcGFueSBh cGFydCBmcm 9tIG90aGVy IHBoYXJtYW NldXRpY2Fs IGNvbXBhbm llczogPGJy PjEuIEZvY3 VzIG9uIE9w aHRoYWxtb2 xvZ3k6IFNh bnRlbiBzcG VjaWFsaXpl cyBpbiBwaG FybWFjZXV0 aWNhbHMgYW 5kIG1lZGlj YWwgZGV2aW NlcyBmb3Ig b3BodGhhbG 1pYyBkaXNl YXNlcyBhbm QgY29uZGl0 aW9ucy4gVG hpcyBmb2N1 c2VkIGFwcH JvYWNoIGFs bG93cyB0aG VtIHRvIGJl IGFuIGV4cG VydCBpbiBl eWUgaGVhbH RoIGFuZCBw cm92aWRlIG lubm92YXRp dmUgdHJlYX RtZW50cyBm b3IgcGF0aW VudHMgd2l0 aCBleWUgZG lzZWFzZXMg YW5kIGRpc2 9yZGVycy4g PGJyPjIuIE dsb2JhbCBQ cmVzZW5jZT ogU2FudGVu IGlzIGEgZ2 xvYmFsIGNv bXBhbnkgd2 l0aCBhIHN0 cm9uZyBwcm VzZW5jZSBp biBBc2lhLC BFdXJvcGUs IGFuZCB0aG UgVW5pdGVk IFN0YXRlcy 4gVGhpcyBh bGxvd3MgdG hlbSB0byBy ZWFjaCBhIH dpZGVyIG1h cmtldCBhbm QgcHJvdmlk ZSB0aGVpci Bwcm9kdWN0 cyB0byBhIG RpdmVyc2Ug cmFuZ2Ugb2 YgcGF0aWVu dHMgd29ybG R3aWRlLiA8 YnI+My4gQ2 9tbWl0bWVu dCB0byBSZX NlYXJjaCBh bmQgRGV2ZW xvcG1lbnQ6 IFNhbnRlbi BpbnZlc3Rz IGhlYXZpbH kgaW4gcmVz ZWFyY2ggYW 5kIGRldmVs b3BtZW50LC B3aXRoIGEg Zm9jdXMgb2 4gaW1wcm92 aW5nIHBhdG llbnQgb3V0 Y29tZXMgYW 5kIGRldmVs b3Bpbmcgbm V3IHRyZWF0 bWVudHMgZm 9yIGV5ZSBk aXNlYXNlcy 4gVGhleSBo YXZlIGEgZG VkaWNhdGVk IFImRCBjZW 50ZXIgYW5k IGNvbGxhYm 9yYXRpb25z IHdpdGggbG VhZGluZyBy ZXNlYXJjaC BpbnN0aXR1 dGlvbnMuID xicj40LiBT dXN0YWluYW JpbGl0eTog U2FudGVuIG lzIGNvbW1p dHRlZCB0by BzdXN0YWlu YWJpbGl0eS BhbmQgZXRo aWNhbCBidX NpbmVzcyBw cmFjdGljZX MuIFRoZXkg aGF2ZSBpbX BsZW1lbnRl ZCBpbml0aW F0aXZlcyB0 byByZWR1Y2 UgdGhlaXIg ZW52aXJvbm 1lbnRhbCBp bXBhY3QgYW 5kIHByb21v dGUgc29jaW FsIHJlc3Bv bnNpYmlsaX R5LCBzdWNo IGFzIHVzaW 5nIGVjby1m cmllbmRseS BtYXRlcmlh bHMgYW5kIH Byb21vdGlu ZyBkaXZlcn NpdHkgYW5k IGluY2x1c2 lvbiB3aXRo aW4gdGhlIG NvbXBhbnku IDxicj41Li BQYXRpZW50 LUNlbnRyaW MgQXBwcm9h Y2g6IFNhbn RlbiBwdXRz IHRoZSBwYX RpZW50IGF0 IHRoZSBjZW 50ZXIgb2Yg ZXZlcnl0aG luZyB0aGV5 IGRvLCB3aX RoIGEgZ29h bCBvZiBpbX Byb3Zpbmcg dGhlIHF1YW xpdHkgb2Yg bGlmZSBmb3 IgdGhvc2Ug YWZmZWN0ZW QgYnkgZXll IGRpc2Vhc2 VzLiBUaGV5 IHN0cml2ZS B0byBsaXN0 ZW4gdG8gcG F0aWVudHMg YW5kIGhlYW x0aGNhcmUg cHJvZmVzc2 lvbmFscyBh bmQgZGV2ZW xvcCBwcm9k dWN0cyB0aG F0IG1lZXQg dGhlaXIgbm VlZHMuIDxi cj42LiBQYX J0bmVyc2hp cCBhbmQgQ2 9sbGFib3Jh dGlvbjogU2 FudGVuIHBh cnRuZXJzIH dpdGggb3Ro ZXIgY29tcG FuaWVzIGFu ZCBvcmdhbm l6YXRpb25z IHRvIGRldm Vsb3AgbmV3 IHRyZWF0bW VudHMgYW5k IGltcHJvdm UgcGF0aWVu dCBjYXJlLi BUaGV5IGFs c28gY29sbG Fib3JhdGUg d2l0aCBwYX RpZW50IG9y Z2FuaXphdG lvbnMgYW5k IGFkdm9jYW N5IGdyb3Vw cyB0byByYW lzZSBhd2Fy ZW5lc3MgYW JvdXQgZXll IGhlYWx0aC BhbmQgc3Vw cG9ydCBwYX RpZW50cy4=

VGhlIFNhbn RlbiBQaGFy bWFjZXV0aW NhbCBjb21w YW554oCZcy BidXNpbmVz cyBtb2RlbC Bmb2N1c2Vz IG9uIHJlc2 VhcmNoLCBk ZXZlbG9wbW VudCwgcHJv ZHVjdGlvbi wgYW5kIG1h cmtldGluZy BvZiBwaGFy bWFjZXV0aW NhbHMgYW5k IG1lZGljYW wgZGV2aWNl cyBpbiB0aG Ugb3BodGhh bG1pYyBmaW VsZC4gVGhl aXIgbWFpbi Bwcm9kdWN0 cyBpbmNsdW RlIHByZXNj cmlwdGlvbi BkcnVncywg b3Zlci10aG UtY291bnRl ciBwcm9kdW N0cywgYW5k IG1lZGljYW wgZGV2aWNl cyBmb3IgdH JlYXRtZW50 IG9mIHZhcm lvdXMgZXll IGRpc2Vhc2 VzIGFuZCBj b25kaXRpb2 5zLiBUaGV5 IGFsc28gaG F2ZSBhIHN0 cm9uZyBwcm VzZW5jZSBp biBpbnRlcm 5hdGlvbmFs IG1hcmtldH MgdGhyb3Vn aCBwYXJ0bm Vyc2hpcHMg YW5kIGNvbG xhYm9yYXRp b25zIHdpdG ggb3RoZXIg cGhhcm1hY2 V1dGljYWwg Y29tcGFuaW VzLiBUaGUg Y29tcGFuee KAmXMgYnVz aW5lc3Mgc3 RyYXRlZ3kg aXMgYmFzZW Qgb24gaW5u b3ZhdGlvbi wgcXVhbGl0 eSwgYW5kIG dsb2JhbCBl eHBhbnNpb2 4gdG8gbWVl dCB0aGUgbm VlZHMgb2Yg cGF0aWVudH MgYW5kIGhl YWx0aGNhcm UgcHJvZmVz c2lvbmFscy 4=

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDIwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvZT Q0aDJFZzFJ VkFZNmYxWW R3Nkwud2Vi cCIgYWx0PS JTYW50ZW4g UGhhcm1hY2 V1dGljYWwi IHRpdGxlPS JTYW50ZW4g UGhhcm1hY2 V1dGljYWwi ICBjbGFzcz 0iaW1nLWZs dWlkIiBoZW lnaHQ9OTAg d2lkdGg9OT AgbG9hZGlu Zz0nbGF6eS cgc3R5bGU9 J2JvcmRlci 1yYWRpdXM6 IDZweDsnPg oKICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdmbGV4 OiAxOyB0ZX h0LWFsaWdu OiBjZW50ZX I7IG1hcmdp bi1sZWZ0Oi A1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPHAgc3R5 bGU9J2Zvbn Qtc2l6ZTog MjZweDsgY2 9sb3I6ICMz MzM7IG1hcm dpbi1ib3R0 b206IDE1cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk4gg V2FudCB0by ByZWFkIG1v cmUgYWJvdX QgU2FudGVu IFBoYXJtYW NldXRpY2Fs PwogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdpbm RleC5waHA/ cGFnZT1zaW dudXAnIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJhY2 tncm91bmQt Y29sb3I6IC MwMDdCRkY7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBj b2xvcjogI2 ZmZjsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH ggMjBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJv cmRlci1yYW RpdXM6IDVw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHRleHQtZG Vjb3JhdGlv bjogbm9uZT sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG ZvbnQtd2Vp Z2h0OiBib2 xkOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgbWFyZ2lu LXJpZ2h0Oi AxMHB4Owog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdHJh bnNpdGlvbj ogYmFja2dy b3VuZC1jb2 xvciAwLjNz IGVhc2U7Jw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgb2 5tb3VzZW92 ZXI9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA1Nm IzIicKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG9ubW91 c2VvdXQ9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A3QkZGIic+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG ZvciBmcmVl CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxzcGFu IHN0eWxlPS dtYXJnaW46 IDAgOHB4Oy Bjb2xvcjog IzU1NTsnPm 9yPC9zcGFu PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9bG 9naW4nIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGNvbG 9yOiAjMDA3 QkZGOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdGV4dC 1kZWNvcmF0 aW9uOiB1bm RlcmxpbmU7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBm b250LXdlaW dodDogNTAw Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBsb2cgaW 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg oKCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdt YXJnaW4tdG 9wOiAxNXB4 OyBmb250LX NpemU6IDEz cHg7IGZvbn Qtd2VpZ2h0 OiBib2xkOy Bjb2xvcjog I2QzMmYyZj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag8J+UkyBV bmxvY2sgb3 VyIGZyZWUg Z3VpZGU6ID xpPiJUaGUg Q2hlY2tsaX N0IFZhbHVl IEludmVzdG 9yIOKAlCBB IFNtYXJ0ZX IgV2F5IHRv IFBpY2sgU3 RvY2tzIjwv aT4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPCEt LQogICAgIC AgICAgICAg ICAgICAgIC AgICA8ZGl2 IHN0eWxlPS dtYXJnaW4t dG9wOiAxMn B4OyBmb250 LXNpemU6ID EzcHg7IGNv bG9yOiAjND Q0Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIG5vdy BhbmQgZ2V0 IG91ciBmcm VlIGVCb29r IAogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PGI+VGhlIE NoZWNrbGlz dCBWYWx1ZS BJbnZlc3Rv ciDigJQgQS BTbWFydGVy IFdheSB0by BQaWNrIFN0 b2NrczwvYj 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIC0tPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8IS0tCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxkaXYgc3 R5bGU9J21h cmdpbi10b3 A6IDEycHg7 IGZvbnQtc2 l6ZTogMTNw eDsgY29sb3 I6ICM0NDQ7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IEhhdmUgeW 91IGhlYXJk IGFib3V0IG 91ciBzaG9y dCA8Yj5EYW lseSBWaWRl byBOZXdzbG V0dGVyPC9i Pj8KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IDxhIGhyZW Y9J2h0dHBz Oi8vd3d3Lm luc2lnaHRm dWx2YWx1ZS 5jb20vbmV3 c2xldHRlci 5waHAnIHRh cmdldD0nX2 JsYW5rJyBz dHlsZT0nY2 9sb3I6ICMw MDdCRkY7IH RleHQtZGVj b3JhdGlvbj ogbm9uZTsg Zm9udC13ZW lnaHQ6IDUw MDsgbWFyZ2 luLWxlZnQ6 IDVweDsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIEZpbmQg b3V0IG1vcm UKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC 0tPgogICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICAKICAgIC AgICAKICAg ICAgICA8c3 BhbiBjbGFz cz0nYmx1cn JlZC10ZXh0 Jz4KICAgIC AgICAgICAg TVM0Z1UyRn VkRyBWdUlG Qm9ZWEp0IF lXTmxkWFJw WTIgRnNJRU 52TGl3ZyBU SFJrTGlCaV pXIGRoYmlC cGRITWcgYU hWdFlteGxJ RyBwdmRYSn VaWGtnIGFX NGdTbUZ3WV cgNGdZWE1n WVNCMyBhRz lzWlhOaGJH IFVnWkhKMV oyZHAgYzNR Z2FXNGdNVC BnNU1Dd2dk VzVrIFpYSW dkR2hsSUcg NWhiV1VnUm 5WciBkV2ho Y21FZ1MyIG wwWVdkaGQy RWcgVTJodm RHVnVMaiB4 aWNqNHlMaU JKIGJpQXhP VEU1TEMgQk dkV3QxYUdG eSBZU0JMYV hSaFoyIEYz WVNCVGFHOT AgWlc0Z2Qy RnpJRyBsdV kyOXljRzl5 IFlYUmxaQ0 JoYm0gUWdj bVZ1WVcxbC BaQ0JUWVc1 MFpXIDRnVU doaGNtMWgg WTJWMWRHbG pZVyB3Z1Ey OHVMQ0JNIG RHUXVJRlJv WlMgQmpiMj F3WVc1NSBJ SGRoY3lCbW IyIE4xYzJW a0lHOXUgSU hSb1pTQndj bSA5a2RXTj BhVzl1IElH OW1JR1Y1Wl MgQmtjbTl3 Y3lCaCBibV FnYjNSb1pY IElnWlhsbE lHTmggY21V Z2NISnZaSC BWamRITXVQ R0p5IFBqTX VJRlJ2Wkcg RjVMQ0JUWV c1MCBaVzRn YVhNZ2IyID VsSUc5bUlI Um8gWlNCc1 lYSm5aWCBO MElFcGhjR0 Z1IFpYTmxJ R052YlggQm hibWxsY3lC MCBhR0YwSU hOd1pXIE5w WVd4cGVtVn ogSUdsdUlI Um9aUyBCa1 pYWmxiRzl3 IGJXVnVkQ3 dnY0ggSnZa SFZqZEdsdi BiaXdnWVc1 a0lHIDFoY2 10bGRHbHUg WnlCdlppQn ZjRyBoMGFH RnNiV2xqIE lIQm9ZWEp0 WVcgTmxkWF JwWTJGcyBj eXdnYldWa2 FXIE5oYkNC a1pYWnAgWT JWekxDQmhi bSBRZ2IzWm xjaTEwIGFH VXRZMjkxYm 4gUmxjaUJs ZVdVZyBZMk Z5WlNCd2Nt IDlrZFdOMG N5NDggWW5J K05DNGdWRy BobElHTnZi WEJoIGJua2 dhR0Z6SUcg RWdjM1J5Yj I1biBJR2x1 ZEdWeWJtIE YwYVc5dVlX d2cgY0hKbG MyVnVZMiBV c0lIZHBkR2 dnIGIzQmxj bUYwYVcgOX VjeUJwYmlC diBkbVZ5SU RZd0lHIE52 ZFc1MGNtbG wgY3lCaGJt UWdjbSBWbm FXOXVjeUIz IGIzSnNaSG RwWkcgVXVQ R0p5UGpVdS BJRk5oYm5S bGJ1IEtBbV hNZ1kyOXkg Y0c5eVlYUm xJRyAxcGMz TnBiMjRnIG FYTWdkRzhn WTIgOXVkSE pwWW5WMCBa U0IwYnlCMG FHIFVnZDJW c2JDMWkgWl dsdVp5QnZa aSBCd1lYUn BaVzUwIGN5 QmllU0J3Y2 0gOTJhV1Jw Ym1jZyBhVz V1YjNaaGRH IGwyWlN3Z2 FHbG4gYUMx eGRXRnNhWC BSNUlIQnli MlIxIFkzUn pJR0Z1WkMg QnpaWEoyYV dObCBjeUJw YmlCMGFHIF VnWm1sbGJH UWcgYjJZZ2 IzQm9kRyBo aGJHMXZiRz luIGVTNDhZ bkkrTmkgNG dVMkZ1ZEdW dSBJR2hoY3 lCaElIIE4w Y205dVp5Qm ogYjIxdGFY UnRaVyA1ME lIUnZJSEps IGMyVmhjbU 5vSUcgRnVa Q0JrWlhabC BiRzl3YldW dWRDIHdnYV c1MlpYTjAg YVc1bklHOT JaWCBJZ01q QWxJRzltIE lHbDBjeUJ5 WlggWmxibl ZsSUdsdSBJ SFJvWlNCa1 pYIFpsYkc5 d2JXVnUgZE NCdlppQnVa WCBjZ2NISn ZaSFZqIGRI TWdZVzVrSU ggUmxZMmh1 YjJ4diBaMm xsY3k0OFlu IEkrTnk0Z1 ZHaGwgSUdO dmJYQmhibi BrZ2FYTWdh MjV2IGQyNG dabTl5SUcg bDBjeUJsZU hCbCBjblJw YzJVZ2FXID RnZEdobElI UnkgWldGMG JXVnVkQyBC dlppQm5iR0 YxIFkyOXRZ U3dnWkggSj VJR1Y1WlNC ayBhWE5sWV hObExDIEJo Ym1RZ2IzUm 8gWlhJZ1pY bGxJRyBScG MyOXlaR1Z5 IGN5NGdTWF FnWVcgeHpi eUJ2Wm1abC Bjbk1nWVNC eVlXIDVuWl NCdlppQnog ZFhKbmFXTm hiQyBCd2Nt OWtkV04wIG N5Qm1iM0ln WTIgRjBZWE poWTNRZyBZ VzVrSUdkc1 lYIFZqYjIx aElITjEgY2 1kbGNtbGxj eSA0OFluSS tPQzRnIFUy RnVkR1Z1SU cgaGhjeUJ5 WldObCBhWF psWkNCdWRX IDFsY205MW N5QmggZDJG eVpITWdZVy A1a0lHRmpZ MjlzIFlXUm xjeUJtYjMg SWdhWFJ6SU dOdiBiVzFw ZEcxbGJuIF FnZEc4Z1ky OXkgY0c5eV lYUmxJSCBO dlkybGhiQ0 J5IFpYTndi MjV6YVcgSn BiR2wwZVN3 ZyBjM1Z6ZE dGcGJtIEZp YVd4cGRIa3 MgSUdGdVpD QmxkRyBocF kyRnNJR0ox IGMybHVaWE 56SUggQnlZ V04wYVdObC BjeTQ4WW5J K09TIDRnU1 c0Z1lXUmsg YVhScGIyNG dkRyA4Z2FY UnpJSEJvIF lYSnRZV05s ZFggUnBZMk ZzSUhCeSBi MlIxWTNSek xDIEJUWVc1 MFpXNGcgWV d4emJ5QnZa bSBabGNuTW dZU0J5IFlX NW5aU0J2Wm kgQnViMjR0 Y0doaCBjbT FoWTJWMWRH IGxqWVd3Z2 NISnYgWkhW amRITXNJRy BsdVkyeDFa R2x1IFp5Qm piMjUwWVcg TjBJR3hsYm 5ObCBjeXdn WlhsbElHIE 5oY21VZ2Mz VncgY0d4bG JXVnVkSCBN c0lHRnVaQ0 J0IFpXUnBZ MkZzSUcgUm xkbWxqWlhN dSBQR0p5UG pFd0xpIEJF WlhOd2FYUm wgSUdsMGN5 Qm5iRyA5aV lXd2djM1Zq IFkyVnpjeX dnVTIgRnVk R1Z1SUhKbC BiV0ZwYm5N Z1lTIEJtWV cxcGJIa3Qg Y25WdUlHTn ZiWCBCaGJu a2dkMmwwIG FDQjBhR1Vn Wm0gOTFjbl JvSUdGdSBa Q0JtYVdaMG FDIEJuWlc1 bGNtRjAgYV c5dWN5QnZa aSBCMGFHVW diM0pwIFoy bHVZV3dnWm 0gOTFibVJs Y25NZyBjM1 JwYkd3Z2FX IDUyYjJ4Ml pXUWcgYVc0 Z2RHaGxJRy BKMWMybHVa WE56IExpQl VhR2x6SUcg aGhjeUJvWl d4dyBaV1Fn ZEc4Z2JXIE ZwYm5SaGFX NGcgWVNCem RISnZibSBj Z2MyVnVjMl VnIGIyWWdk SEpoWkcgbD BhVzl1TENC aiBiMjF0YV hSdFpXIDUw SUhSdklHVj QgWTJWc2JH VnVZMiBVc0 lHRnVaQ0Jr IFpXUnBZMk YwYVcgOXVJ SFJ2SUhCaC BkR2xsYm5R Z1kyIEZ5Wl M0PQogICAg ICAgIDwvc3 Bhbj4KICAg ICAgICAKIC AgICAgICA=
See Company Q&A